Elevation Oncology Stock Price Prediction
| ELEV Stock | USD 0.61 0.03 5.17% |
Oversold Vs Overbought
50
Oversold | Overbought |
EPS Estimate Next Quarter (0.21) | EPS Estimate Current Year (0.79) | EPS Estimate Next Year (0.82) | Wall Street Target Price 7 | EPS Estimate Current Quarter (0.20) |
Using Elevation Oncology hype-based prediction, you can estimate the value of Elevation Oncology from the perspective of Elevation Oncology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Elevation Oncology to buy its stock at a price that has no basis in reality. In that case, they are not buying Elevation because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Elevation Oncology after-hype prediction price | USD 0.6 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Elevation |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Elevation Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Elevation Oncology After-Hype Price Prediction Density Analysis
As far as predicting the price of Elevation Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Elevation Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Elevation Oncology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Elevation Oncology Estimiated After-Hype Price Volatility
In the context of predicting Elevation Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Elevation Oncology's historical news coverage. Elevation Oncology's after-hype downside and upside margins for the prediction period are 0.03 and 5.11, respectively. We have considered Elevation Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Elevation Oncology is dangerous at this time. Analysis and calculation of next after-hype price of Elevation Oncology is based on 3 months time horizon.
Elevation Oncology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Elevation Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Elevation Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Elevation Oncology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.34 | 4.56 | 0.00 | 0.02 | 10 Events / Month | 4 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.61 | 0.60 | 3.45 |
|
Elevation Oncology Hype Timeline
Elevation Oncology is currently traded for 0.61. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. Elevation is forecasted to increase in value after the next headline, with the price projected to jump to 0.6 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is projected to be 3.45%, whereas the daily expected return is currently at -0.34%. The volatility of related hype on Elevation Oncology is about 9771.43%, with the expected price after the next announcement by competition of 0.63. Elevation Oncology currently holds 30.14 M in liabilities. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Elevation Oncology Basic Forecasting Models to cross-verify your projections.Elevation Oncology Related Hype Analysis
Having access to credible news sources related to Elevation Oncology's direct competition is more important than ever and may enhance your ability to predict Elevation Oncology's future price movements. Getting to know how Elevation Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Elevation Oncology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CWBR | CohBar Inc | 0.07 | 3 per month | 5.34 | 0.08 | 5.73 | (5.59) | 250.97 | |
| OCEA | Ocean Biomedical | 0.01 | 2 per month | 0.00 | (0.12) | 7.46 | (6.93) | 28.33 | |
| AVRO | AVROBIO | 0.05 | 5 per month | 1.89 | 0.02 | 4.11 | (3.17) | 14.20 | |
| ZURA | Zura Bio Limited | 0.03 | 9 per month | 0.00 | (0.05) | 7.95 | (7.94) | 30.69 | |
| ENVB | Enveric Biosciences | 0.08 | 5 per month | 0.00 | (0.16) | 6.25 | (7.50) | 28.33 | |
| HEPA | Hepion Pharmaceuticals | 0.04 | 3 per month | 4.43 | (0.01) | 8.06 | (8.11) | 33.54 |
Elevation Oncology Additional Predictive Modules
Most predictive techniques to examine Elevation price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Elevation using various technical indicators. When you analyze Elevation charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Elevation Oncology Predictive Indicators
The successful prediction of Elevation Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Elevation Oncology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Elevation Oncology based on analysis of Elevation Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Elevation Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Elevation Oncology's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 17.0 | 5.93 | 21.22 | 22.28 | Net Debt To EBITDA | 4.57 | 0.17 | 0.46 | 0.44 |
Story Coverage note for Elevation Oncology
The number of cover stories for Elevation Oncology depends on current market conditions and Elevation Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Elevation Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Elevation Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Elevation Oncology Short Properties
Elevation Oncology's future price predictability will typically decrease when Elevation Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Elevation Oncology often depends not only on the future outlook of the potential Elevation Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Elevation Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 34.1 M | |
| Cash And Short Term Investments | 83.1 M |
Additional Tools for Elevation Stock Analysis
When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.